Mourad Gumusboga

729 total citations
20 papers, 494 citations indexed

About

Mourad Gumusboga is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Mourad Gumusboga has authored 20 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Mourad Gumusboga's work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (9 papers) and Pneumonia and Respiratory Infections (5 papers). Mourad Gumusboga is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (9 papers) and Pneumonia and Respiratory Infections (5 papers). Mourad Gumusboga collaborates with scholars based in Belgium, Bangladesh and France. Mourad Gumusboga's co-authors include Armand Van Deun, Bouke C. de Jong, Leen Rigouts, Willem Bram de Rijk, Cécile Uwizeye, K. J. M. Aung, Pim de Rijk, M A Hossain, Md Anwar Hossain and K. Fissette and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Mourad Gumusboga

19 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mourad Gumusboga Belgium 11 463 428 152 72 50 20 494
M A Hossain Bangladesh 8 397 0.9× 350 0.8× 125 0.8× 47 0.7× 33 0.7× 20 440
K. J. M. Aung Bangladesh 11 704 1.5× 639 1.5× 259 1.7× 95 1.3× 62 1.2× 20 741
Willem Bram de Rijk Belgium 7 456 1.0× 445 1.0× 181 1.2× 69 1.0× 54 1.1× 9 489
Belén Imperiale Argentina 12 344 0.7× 336 0.8× 97 0.6× 83 1.2× 51 1.0× 30 407
K. Fissette Belgium 15 647 1.4× 667 1.6× 232 1.5× 104 1.4× 69 1.4× 27 762
Afton Dorasamy South Africa 8 258 0.6× 251 0.6× 57 0.4× 51 0.7× 29 0.6× 9 332
Camus Nimmo United Kingdom 10 258 0.6× 242 0.6× 79 0.5× 77 1.1× 27 0.5× 18 341
Hanna Nebenzahl-Guimaraes Portugal 8 263 0.6× 241 0.6× 96 0.6× 99 1.4× 29 0.6× 11 291
Avisek Banerjee United States 3 331 0.7× 328 0.8× 124 0.8× 84 1.2× 81 1.6× 5 393
Jianhao Wei China 11 252 0.5× 232 0.5× 72 0.5× 81 1.1× 69 1.4× 16 324

Countries citing papers authored by Mourad Gumusboga

Since Specialization
Citations

This map shows the geographic impact of Mourad Gumusboga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mourad Gumusboga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mourad Gumusboga more than expected).

Fields of papers citing papers by Mourad Gumusboga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mourad Gumusboga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mourad Gumusboga. The network helps show where Mourad Gumusboga may publish in the future.

Co-authorship network of co-authors of Mourad Gumusboga

This figure shows the co-authorship network connecting the top 25 collaborators of Mourad Gumusboga. A scholar is included among the top collaborators of Mourad Gumusboga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mourad Gumusboga. Mourad Gumusboga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rigouts, Leen, Mourad Gumusboga, Morten Rühwald, et al.. (2024). Successful Mycobacterium tuberculosis culture isolation from tongue swabs: Results from both experimentally infected and clinical swabs from pulmonary tuberculosis patients. Diagnostic Microbiology and Infectious Disease. 110(2). 116423–116423.
2.
Deun, Armand Van, Michel Kaswa, M. Anwar Hossain, et al.. (2022). Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings. JAC-Antimicrobial Resistance. 4(2). dlac037–dlac037. 3 indexed citations
3.
Achan, Beatrice, Benon Asiimwe, Moses Joloba, et al.. (2021). The simple direct slide method is comparable to indirect Lowenstein Jensen proportion culture for detecting rifampicin resistant tuberculosis. Journal of Medical Microbiology. 70(3). 3 indexed citations
4.
Maug, Aung Kya Jai, M A Hossain, Mourad Gumusboga, et al.. (2021). Finding the right balance between efficacy and tolerability for TB treatment: the search continues. The International Journal of Tuberculosis and Lung Disease. 25(1). 84–86. 1 indexed citations
5.
Maug, Aung Kya Jai, M A Hossain, Mourad Gumusboga, et al.. (2020). First-line tuberculosis treatment with double-dose rifampicin is well tolerated. The International Journal of Tuberculosis and Lung Disease. 24(5). 499–505. 15 indexed citations
6.
Deun, Armand Van, Tom Decroo, Aung Kya Jai Maug, et al.. (2020). The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance. PLoS ONE. 15(5). e0233500–e0233500. 13 indexed citations
7.
Decroo, Tom, Aung Kya Jai Maug, M. Anwar Hossain, et al.. (2020). Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes. PLoS ONE. 15(8). e0238016–e0238016. 6 indexed citations
8.
Torrea, Gabriela, Armand Van Deun, Emmanuel André, et al.. (2019). Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. Scientific Reports. 9(1). 11826–11826. 33 indexed citations
9.
Piubello, Alberto, Mahamadou Bassirou Souleymane, Abdourahamane Yacouba, et al.. (2019). Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements. Respiratory Medicine. 161. 105844–105844. 27 indexed citations
10.
Deshpande, Devyani, Jotam G. Pasipanodya, Shashikant Srivastava, et al.. (2018). Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis. Clinical Infectious Diseases. 67(suppl_3). S274–S283. 20 indexed citations
11.
Deun, Armand Van, K. J. M. Aung, M A Hossain, et al.. (2018). Twenty years of rifampicin resistance surveillance in Bangladesh: periodic vs. continuous monitoring. The International Journal of Tuberculosis and Lung Disease. 22(12). 1450–1461. 3 indexed citations
12.
Daneau, Géraldine, Mourad Gumusboga, Pim de Rijk, et al.. (2016). The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide. International Journal of Mycobacteriology. 5. S46–S47. 7 indexed citations
13.
Rigouts, Leen, Nele Coeck, Mourad Gumusboga, et al.. (2015). SpecificgyrAgene mutations predict poor treatment outcome in MDR-TB. Journal of Antimicrobial Chemotherapy. 71(2). 314–323. 62 indexed citations
14.
Deun, Armand Van, K. J. M. Aung, Md Anwar Hossain, et al.. (2015). Disputed <I>rpo</I>B mutations can frequently cause important rifampicin resistance among new tuberculosis patients. The International Journal of Tuberculosis and Lung Disease. 19(2). 185–190. 74 indexed citations
15.
Deun, Armand Van, et al.. (2014). An operational study comparing microscopes and staining variations for tuberculosis LED FM. The International Journal of Tuberculosis and Lung Disease. 18(8). 964–971. 2 indexed citations
16.
Rigouts, Leen, Mourad Gumusboga, Willem Bram de Rijk, et al.. (2013). Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations. Journal of Clinical Microbiology. 51(8). 2641–2645. 157 indexed citations
17.
Deun, Armand Van, Aung Kya Jai Maug, Arman Hossain, Mourad Gumusboga, & Bouke C. de Jong. (2012). Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 16(9). 1174–1179. 16 indexed citations
18.
Salim, A Hamid, et al.. (2010). Methylene blue is a good background stain for tuberculosis light-emitting diode fluorescence microscopy.. PubMed. 14(12). 1571–5. 2 indexed citations
19.
Deun, Armand Van, et al.. (2008). Performance and acceptability of the FluoLED Easy module for tuberculosis fluorescence microscopy.. PubMed. 12(9). 1009–14. 30 indexed citations
20.
Deun, Armand Van, et al.. (2008). Ziehl-Neelsen staining: theory and practice.. PubMed. 12(1). 108–10. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M A Hossain Breakdown of academic impact, for papers by K. J. M. Aung Breakdown of academic impact, for papers by Willem Bram de Rijk Breakdown of academic impact, for papers by Belén Imperiale Breakdown of academic impact, for papers by K. Fissette Breakdown of academic impact, for papers by Afton Dorasamy Breakdown of academic impact, for papers by Camus Nimmo Breakdown of academic impact, for papers by Hanna Nebenzahl-Guimaraes Breakdown of academic impact, for papers by Avisek Banerjee Breakdown of academic impact, for papers by Jianhao Wei
Rankless by CCL
2026